¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Opioid reactor antagonists"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® opioid ÇÑ±Û ¾ÆÆíÀ¯»çÁ¦
¼³¸í   
  1. ¾ÆÆíÁ¦Á¦¿Í °°Àº ÀÛ¿ëÀ» °¡Áø ÇÕ¼º¸¶¾àÀ¸·Î¼­ ¾ÆÆíÀ¯µµÃ¼°¡ ¾Æ´Ñ °Í. Á¾·ù·Î´Â heroin, meperidine, dihydromorphine(Dilaudid), methadone µîÀÌ ÀÖ´Ù. 2. ¼¼Æ÷¸·ÀÇ ¾ÆÆíÁ¦Á¦ ¼ö¿ëü¿Í »óÈ£ÀÛ¿ëÇÔÀ¸·Î½á ¾ÆÆíÁ¦Á¦¿Í °°Àº È¿°ú¸¦ ³ªÅ¸³»´Â Ãµ¿¬»ê ÆéƼµå.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactor
    1. ¹ÝÀÀ±â 2. ¹ÝÀÀ¿ë±â 3. ¿øÀÚ·Î
  • opioid
    ¾ÆÆíÀ¯»çÁ¦
  • opioid agonist
    ¾ÆÆíÀ¯»çÀÛ¿ëÁ¦
  • opioid analgesic
    ¾ÆÆíÀ¯»çÁøÅëÁ¦
  • opioid antagonist
    ¾ÆÆíÀ¯»çÁ¦´ëÇ×Á¦
  • opioid receptor
    ¾ÆÆíÀ¯»çÁ¦¼ö¿ëü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • opioid
    ¾ÆÆíÀ¯»çÁ¦
  • reactor
    ¹ÝÀÀ±â
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reactor
    ¹ÝÀÀ±â
  • transient light reactor
    Àϰú¼º±¤¼±¹ÝÀÀ±â
  • opioid agonist
    ¾ÆÆíÀ¯»çÀÛ¿ëÁ¦
  • opioid analgesic
    ¾ÆÆíÀ¯»çÁøÅëÁ¦
  • opioid antagonist
    ¾ÆÆíÀ¯»ç¹°Áú´ëÇ×Á¦
  • opioid
    ¾ÆÆíÀ¯»çÁ¦
  • opioid receptor
    ¾ÆÆíÀ¯»ç¹°Áú¼ö¿ëü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • transient light reactor
    Àϰú¼º ±¤¼±¹ÝÀÀ±â (¡­ÎÃàÊÚãëëÐï).
  • transient light reactor
    Àϰú¼º ±¤¼±¹ÝÀÀ±â (¡­ÎÃàÊÚãëëÐï)
  • opioid
    ¾ÆÆíÀ¯»ç¾à¹°, ¾ÆÆí¾çÁ¦Á¦.
  • opioid
    ¾ÆÆí¾çÁ¦Á¦
  • opioid
    ¾ÆÆíÀ¯»ç¾à¹°, ¾ÆÆí¾çÁ¦Á¦.
  • opioid
    ¾ÆÆí(¾ç)Á¦Á¦
  • opioid
    ¾ÆÆíÀ¯»ç¾à¹°, ¾ÆÆí°èÁ¦Á¦.
  • opioid
    ¾ÆÆí¾çÁ¦Á¦(¾ÆÆíÁ¦¼ö¿ëü¿¡ ÀÛ¿ë,¾ÆÆíÁ¦¿Í
  • opioid abuse
  • opioid agonist
    ¾ÆÆí¾çÀÛ¿ëÁ¦
  • opioid analgesic
    ¾ÆÆí¾çÁøÅëÁ¦.
  • opioid analgesic
    ¾ÆÆíÀ¯»çÁøÅëÁ¦, ¾ÆÆí°èÁøÅëÁ¦.
  • opioid antagonist
    ¾ÆÆí¾ç±æÇ×Á¦
  • opioid dependence
    ¾ÆÆí¾çÁ¦Á¦ ÀÇÁ¸(ëýðí)
  • opioid intoxication
    ¾ÆÆí¾çÁ¦Á¦ Áßµ¶(ñéÔ¸)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glutamine antagonists
    ±Û·çŸ¹Î ±æÇ×Á¦(ÑÏù÷ð¥)
  • reactor
    ¹ÝÀÀ±â(ÚãëëÐï)
  • opioid
    ¾ÆÆí°è(ͧ)¾à¹°(å·Úª)
  • opioid peptide
    ¾ÆÆí°è(ͧ) ÆéŸÀ̵å
  • opioid receptor
    ¾ÆÆí°è(ͧ) ¾à¹°¼ö¿ëü(å·Úªáôé»ô÷)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
POP diphosphate group; pain on palpation; paroxypropione; persistent occipitoposterior [fetal position];...
STR soft tissue relaxation; statherin; stirred tank reactor
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
BMRR Brookhaven Medical Research Reactor
CCA Calcium channel antagonists
C.S.T.R. Continuously Stirred Tank Reactor
H(2)RA H(2) receptor antagonists
LTRA Leukotriene receptor antagonists
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • Y50.1
    Opioid reactor antagonists
    ¾ÆÆí ¼ö¿ëü ´ëÇ×Á¦(±æÇ×Á¦)
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • dopaminergic antagonists
    µµÆÄ¹Î¼ºÀÇ ±æÇ×Á¦
  • opioid
    ¾ÆÆí À¯»ç ¾à¹°, ¾ÆÆí¾ç Á¦Á¦
    1. ¾ÆÆíÁ¦Á¦¿Í °°Àº ÀÛ¿ëÀ» °¡Áø ÇÕ¼º ¸¶¾àÀ¸·Î¼­ ¾ÆÆí À¯µµÃ¼°¡ ¾Æ´Ñ °Í. 2. ¼¼Æ÷¸·ÀÇ ¾ÆÆíÁ¦ ¼ö¿ëü¿Í »óÈ£ ÀÛ¿ëÇÔÀ¸·Î½á ¾ÆÆíÁ¦¿Í °°Àº È¿°ú¸¦ ³ªÅ¸³»´Â õ¿¬»ê ÆéƼµå.
  • opioid dependence
    ¾ÆÆí¾ç Á¦Á¦ ÀÇÁ¸
  • opioid peptide
    ¾ÆÆí¾ç ÆéƼµå, ¾ÆÆí¾ç ÆéŸÀ̵å
  • opioid-mediated analgesia system
    ¾ÆÆí ¸Å°³ ÁøÅë°è
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
opioid antagonists Agents such as naloxone and naltrexone which have high affinity for opiate receptors but do not activate these receptors. These drugs block the effects of exogenously administered opioids such as morphine, heroin, meperidine, and methadone, or of endogenously released endorphins and enkephalins.
(05 Mar 2000)
anoxic reactor A bioreactor which is used to treat wastewater that utterly lacksdissolved oxygen, in it, faculatively anaerobic microbes are able tooxidize the sewage because they use nitrate ions as their oxygen source.
(09 Oct 1997)
boiling water reactor <radiobiology> Class of fission reactor where water is used as a coolant and allowed to boil into steam.
(09 Oct 1997)
breeder reactor <physics> This is a nuclear reactor which produces nuclear fuel as it produces energy for electricity.
(09 Oct 1997)
hollow fibre reactor A fermentation system in which the cells are separated from the medium using semipermeable membranes arranged in the form of hollow fibres.
(14 Nov 1997)
tokamak fusion test reactor <radiobiology> Large tokamak at Princeton, first machine to use 50-50 mix of D-T fuel, current world's record holder in fusion energy production. Largest tokamak in the United States.
(09 Oct 1997)
fission reactor <radiobiology> A device that can initiate and control a self-sustaining series of nuclear fissions, typically used for either research or the production of energy or nuclear weapons materials.
(09 Oct 1997)
fusion reactor <radiobiology> Device which creates energy in a controlled manner through fusion reactions.
(09 Oct 1997)
light-water reactor <radiobiology> Class of fission reactors using ordinary light water as a coolant, rather than liquid metal or heavy water (water with deuterium instead of hydrogen).
(09 Oct 1997)
liquid-metal fast-breeder reactor <physics> Fission breeder reactor concept using liquid-metal coolant and breeding additional fuel off fast neutrons.
See: breeder reactor.
(09 Oct 1997)
analgesics, opioid Narcotic or opioid substances, synthetic or semisynthetic agents producing profound analgesia, drowsiness, and changes in mood. Mood changes may be pleasurable, therefore creating a potential for the abuse of these agents; the prototype of these is morphine to which all other analgesics are compared.
(12 Dec 1998)
receptors, opioid Cell membrane proteins that bind opioids and trigger intracellular changes which influence the behaviour of cells. The endogenous ligands for opioid receptors in mammals include three families of peptides, the enkephalins, endorphins, and dynorphins. The receptor classes include mu, delta, and kappa receptors. Sigma receptors bind several psychoactive substances, including certain opioids, but their endogenous ligands are not known.
(12 Dec 1998)
receptors, opioid, delta A class of opioid receptors recognised by its pharmacological profile. Delta opioid receptors bind endorphins and enkephalins with approximately equal affinity and have less affinity for dynorphins.
(12 Dec 1998)
receptors, opioid, kappa A class of opioid receptors recognised by its pharmacological profile. Kappa opioid receptors bind dynorphins with a higher affinity than endorphins which are themselves preferred to enkephalins.
(12 Dec 1998)
receptors, opioid, mu A class of opioid receptors recognised by its pharmacological profile. Mu opioid receptors bind, in decreasing order of affinity, endorphins, dynorphins, met-enkephalin, and leu-enkephalin. They have also been shown to be molecular receptors for morphine.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • opioid
    ¿ÀÇÇ¿ÀÀ̵å(¾ÆÆí ºñ½ÁÇÑ ÀÛ¿ëÀ» ÇÏ´Â ÇÕ¼º ÁøÅë,¸¶ÃëÁ¦)
  • reactor
    ¿øÀÚ·Î
  • breed reactor
    Áõ½ÄÇü;¿øÀÚ·á
  • chain reactor
    ¿¬¼â ¹ÝÀÀ ÀåÄ¡;¿øÀÚ·Î
  • converter reactor
    (¿¬·á)Àüȯ·Î(¿øÀÚ·ÎÀÇ ÀÏÁ¾)
  • fusion reactor
    ÇÙÀ¶ÇÕ·Î
  • gas cooled reactor
    °¡½º ³Ã°¢·Î
  • graphitic reactor
    Èæ¿¬Çü ¿øÀÚ·Î(carbon reactor¶ó°íµµ ÇÔ)
  • medical reactor
    ÀÇ·á¿ë ¿øÀÚ·Î
  • nuclear reactor
    ¿øÀÚ·Î
  • power reactor
    µ¿·Â·Î
  • pressurized water reactor
    °¡¾Ð¼öÇü ¿øÀÚ·Î
  • production reactor
    »ý»ê¿ë ¿øÀÚ·Î
  • propulsion reactor
    (¿øÀڷ¼± µîÀÇ) ÃßÁø¿ë ¿øÀÚ·Î
  • reactor
    ¹ÝÀÀ(¹Ýµ¿)À» ³ªÅ¸³»´Â »ç¶÷(µ¿¹°);È­ÇÐ ¹ÝÀÀ±â;¹ÝÀÀ ÀåÄ¡;¸®¾×ÅÍ(±³·ù ȸ·Î¿¡ À¯µµ ÀúÇ×À» ÁÖ´Â ÀåÄ¡);¿øÀÚ·Î(pile)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á